Revenue (Tables)

12 Months Ended

Dec. 31, 2023

Revenue [abstract]

Schedule of Revenue Recognized in Consolidated Statement of Profit or Loss

Revenue has been recognized in the consolidated statements of profit or loss with the following amounts:

	2023		2022		2021
	(EUR’000)
Revenue
Sale of commercial products		178,663		35,659		943
Rendering of services		21,659		4,434		751
Sale of clinical supply		319		8,534		3,719
Licenses		66,077		2,547		2,365
Total revenue		266,718		51,174		7,778
Attributable to
Commercial customers		178,663		35,659		943
Collaboration partners and license agreements		88,055		15,515		6,835
Total revenue		266,718		51,174		7,778
Specified by timing of recognition
Recognized over time		21,659		4,434		751
Recognized at a point in time		245,059		46,740		7,027
Total revenue		266,718		51,174		7,778
Specified per geographical location
Europe		869		552		—
North America		191,677		44,156		6,856
Asia		74,172		6,466		922
Total revenue		266,718		51,174		7,778